Fmoc-L-glutamic acid γ-cyclohexyl ester

Fmoc-L-glutamic acid γ-cyclohexyl ester is an Fmoc-protected L-glutamate derivative in which the α-amino group is masked as the fluorenylmethoxycarbonyl carbamate and the γ-carboxyl functionality is esterified with a cyclohexyl group, leaving the α-carboxyl group available for controlled peptide coupling or further functionalization. The molecule contains a stereogenic center at the glutamate α-carbon (L-configuration) and a side-chain γ-ester that modulates polarity, hydrogen-bonding behavior, and compatibility with standard peptide synthesis conditions. The Fmoc group provides orthogonal base-labile protection for iterative N-terminal assembly, while the cyclohexyl ester can serve as a removable protecting group for the side-chain carboxyl to enable selective deprotection and downstream derivatization. The resulting protected amino acid ester is suitable as a chiral intermediate for peptide building block preparation, enabling controlled formation of amide bonds and later conversion of the glutamate side chain into free acid or alternative functional motifs.

1. Peptide Synthesis

Fmoc-L-glutamic acid γ-cyclohexyl ester is applied in solid-phase and solution-phase peptide synthesis where Fmoc protection enables stepwise N-terminal deprotection under basic conditions while maintaining the glutamate stereochemistry. The glutamate backbone presents an Fmoc-carbamate-protected amine for peptide coupling and an esterified γ-carboxyl that can be carried through coupling steps without premature side-chain crosslinking or salt formation. The cyclohexyl γ-ester can be retained during chain assembly to preserve side-chain integrity, then converted to a reactive carboxyl handle for later coupling, branching, or post-assembly modification. Incorporation of this chiral glutamate building block supports construction of peptides with controlled side-chain functionality and predictable protecting-group orthogonality for sequential synthetic logic.

2. Side-Chain Functionalization

Fmoc-L-glutamic acid γ-cyclohexyl ester supports amino acid derivatization workflows targeting glutamate side-chain chemistry, using the γ-carboxyl ester as a protected handle for later transformation. The ester linkage provides a stable functional group during synthetic steps that require selective manipulation of the α-amino terminus, while the cyclohexyl moiety influences reactivity and solubility during intermediate handling. Conversion of the γ-ester to the corresponding free acid or to alternative activated derivatives can enable formation of side-chain amides, mixed anhydrides, or coupling-ready species for conjugation and scaffold elaboration. This design aligns with peptide science and synthetic organic chemistry needs where side-chain functionalization must be temporally controlled to avoid protecting-group incompatibilities.

3. Peptidomimetics And SAR Studies

Fmoc-L-glutamic acid γ-cyclohexyl ester is used in peptidomimetic construction and structure-activity relationship studies where glutamate's carboxylate topology is translated into constrained analogs. The protected amine and protected γ-carboxyl arrangement allows incorporation of the glutamate motif into larger synthetic sequences without uncontrolled side reactions, supporting controlled generation of analog libraries via sequential deprotection and functional group interconversion. The cyclohexyl ester can act as a handle for installing alternative side-chain substituents that preserve stereochemical geometry while tuning polarity and ionization behavior relevant to molecular recognition. Downstream use includes preparation of glutamate-containing fragments and analogs suitable for SAR-driven medicinal chemistry campaigns and binding-site mapping through systematic structural variation.

4. Chemical Biology And Bioconjugation

Fmoc-L-glutamic acid γ-cyclohexyl ester can be applied to chemical biology workflows that require glutamate-based linkers or conjugation-ready intermediates for biomolecule modification. The Fmoc carbamate enables orthogonal handling of the N-terminus during synthesis of peptide tags, affinity handles, or linker segments, while the γ-carboxyl ester provides a protected acidic group that can be converted into a reactive carboxyl functionality when conjugation is required. The stereodefined glutamate side chain supports consistent spatial presentation of acidic groups that often participate in salt-bridge formation and linker stability in bioconjugates. Resulting derivatives can be employed to generate labeled peptides, functional probes, or conjugation intermediates that integrate amino acid chemistry with downstream biomolecule engineering.

5. Pharmaceutical Manufacturing Intermediates

Fmoc-L-glutamic acid γ-cyclohexyl ester serves as a process-relevant intermediate for manufacturing peptide ingredients and peptide-derived intermediates where protecting-group strategy and reproducible coupling behavior are important. The Fmoc group offers a standardized N-protection logic for controlled assembly of glutamate-containing sequences, while the γ-cyclohexyl ester provides a side-chain protection mode that can be managed through orthogonal deprotection steps in a controlled manufacturing route. The chiral L-glutamate framework supports consistent stereochemical outcomes across batch synthesis, which is essential for downstream quality of peptide building blocks and analog intermediates. Utilization in fine chemical synthesis pipelines enables preparation of defined protected amino acid derivatives that can be converted into activated forms for subsequent coupling, formulation building, or controlled release of functional groups during later processing stages.

6. Analytical Research Standards

Fmoc-L-glutamic acid γ-cyclohexyl ester is suitable for analytical research applications where defined protected amino acid standards are needed for method development and impurity profiling in peptide-related workflows. The presence of Fmoc and the cyclohexyl γ-ester creates characteristic chromatographic and spectrometric signatures that facilitate identification of protected glutamate species, monitoring of deprotection progress, and verification of intermediate integrity. The stereochemically defined L-configuration reduces ambiguity in stereoisomeric analysis when developing chiral separation or structural confirmation strategies. Downstream use includes serving as a reference material for characterizing protected amino acid intermediates, validating peptide coupling performance, and supporting analytical method transfer across peptide synthesis and derivative manufacturing contexts.

1. Implications of ligand-receptor binding kinetics on GLP-1R signalling

2. Tachykinin-related peptides modulate immune-gene expression in the mealworm beetle Tenebrio molitor L

3. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate

4. Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis

5. Characterization of Novel P-Selectin Targeted Complement Inhibitors in Murine Models of Hindlimb Injury and Transplantation